Plus: Trijardy XR approval; reversing diabetes with gastric bypass vs. gastric banding vs. diet & exercise; more
Can't see the images? View as webpage.
Facebook
Twitter
LinkedIn
To ensure that you never miss an issue, please whitelist us.

Feb. 1, 2020 : Issue #1027

TOP STORIES - Diabetes News & Research

10 Ways to Get Motivated to Exercise (When You’re Not)
by Sheri Colberg, PhD 

Adjusting Insulin For Dietary Fat

Intensive Glucose Control and Macrovascular Complications 
Letter from the Editor
Feb. 1, 2020

This past week, our four interns learned about basal/bolus dosing and the value of an insulin pump and CGM for managing type one diabetes. We went through the standard calculations to figure out carb ratios and correction factors, and they got plenty of experience figuring out doses based on those ratios. We had them adjust for low glucose, high glucose, and they even managed to figure out how to accurately calculate the actual amount of carbs to raise glucose.

Their next project will be to prove they can make this dosing regimen understandable to patients. Although we know these numbers will work on paper, we often find that even our best calculations go awry in real life. One of the reasons is the composition of our meals and how the amount of fat can affect glucose peak. This week our intern, George McConnell from LECOM College of Pharmacy, gives you the results of a study along with recommendations for adjusting dosing for fat content.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief


Doctor's Option
lab test products include rapid tests and CLIA certified fingerstick lab tests.

Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.

Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.

Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.

Visit Doctor's Option

Newsflash: FDA Approves Trijardy XR Triple-Combination Tablet for Type 2


The FDA has approved a triple-combination tablet (Trijardy XR), comprising empagliflozin (Jardiance), linagliptin (Tradjenta), and extended-release metformin hydrochloride, for the treatment of adults with type 2 diabetes.

TOP STORIES - Diabetes News and Research

10 Ways to Get Motivated to Exercise (When You’re Not)
By Sheri Colberg, PhD
Diabetes is a complex metabolic condition, and your blood glucose levels can impact you not only physically but also emotionally and mentally. Often, feeling depressed or anxious about diabetes management can be demotivating for taking better care of yourself. Whether that care involves getting more physically active or making more healthful food choices, getting and staying more motivated can only benefit you and your blood glucose.
READ MORE
Adjusting Insulin For Dietary Fat
It may be time to start counting fat in addition to carbs to lower A1c effectively.
READ MORE
Intensive Glucose Control and Macrovascular Complications 
Results from a 15-year observational study.
READ MORE

Fact: Reversing Diabetes -- Gastric Bypass vs. Gastric Banding vs. Diet & Exercise


Researchers randomly assigned 61 participants with type 2 diabetes to one of three weight-loss interventions: Roux-en-Y gastric bypass, laparoscopic adjustable gastric banding, or an intensive weight-loss program focused on cutting calories and increasing exercise. Patients were 47 years old on average, living with dangerously elevated blood sugar levels and obesity. The study lasted for five years, and even though this was a small study, the results show a dramatic difference between the three arms of the study.

Any degree of weight loss, even that achieved by non-surgical means (typically about 5% of starting weight as shown in this study), can help control health issues such as diabetes, lipids, and hypertension. After five years, six people who got the Roux-en-Y procedures, or 30%, achieved partial or complete diabetes remission, compared with four people, or 19%, of the participants who had gastric banding, the study found. No one in the diet-and-exercise group achieved remission. Also, 56% of the people who had Roux-en-Y procedures had stopped taking medications to manage diabetes by the end of the study, compared with 45% of the people who had laparoscopic adjustable gastric banding and none of the participants in the lifestyle group. People who had the Roux-en-Y bypass lost an average of 25% of their body weight, compared with about 13% with the lap-band and 5% in the group assigned to intensive lifestyle management.

The conclusion from the study was that people who undergo gastric bypass surgery are more likely to achieve remission of diabetes than those who try to lose weight by dieting and exercising. “The findings add to evidence suggesting that surgical weight loss may be the best approach to achieving diabetes remission," said Dr. Courcoulas of the University of Pittsburgh Medical Center, the study's lead author.

Journal of Clinical Endocrinology & Metabolism, online January 9, 2020. REUTERS

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:

Nadeen Ayad, BCPS, PharmD Candidate, Skaggs School of Pharmacy, University of Colorado

Antonio Bess, Pharm D Candidate, Florida Agricultural & Mechanical University School of Pharmacy

Alessa Grieff, PharmD Candidate, University of South Florida College of Pharmacy

George McConnell, PharmD. Candidate, LECOM School of Pharmacy

 About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com
Facebook
Twitter
LinkedIn
©2020 HIPER, LLC. All rights reserved.

This email was sent by eHealthcare Solutions on behalf of:
Diabetes In Control
810 Bear Tavern Rd, Suite 102
Ewing, NJ, 08628, United States


DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe